3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
58
Neoplasms
51
Lung Neoplasms
33
Colorectal Neoplasms
28
Carcinoma, Non-Small-Cell Lung
25
Prostatic Neoplasms
22
Melanoma
19
Pancreatic Neoplasms
17
Ovarian Neoplasms
16
Uterine Cervical Neoplasms
14
Sarcoma
12
Multiple Myeloma
12
Lymphoma
11
Glioma
11
Glioblastoma
11
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
10
Neoplastic Cells, Circulating
9
Hematologic Neoplasms
9
Lymphoma, Follicular
8
Head and Neck Neoplasms
8
Carcinoma, Hepatocellular
8
Leukemia
7
Endometrial Neoplasms
7
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Papillomavirus Infections
6
Myelodysplastic Syndromes
6
Disease
6
Interventions
Etoposide
30
Carboplatin
30
Cisplatin
23
Ifosfamide
22
Filgrastim
22
Paclitaxel
18
Peripheral Blood Stem Cell Transplantation
16
Bleomycin
13
Cyclophosphamide
11
Radiotherapy
8
Thiotepa
7
Magnetic Resonance Spectroscopy
6
Gemcitabine
6
pegfilgrastim
5
Therapeutics
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Busulfan
5
etoposide phosphate
4
Temozolomide
4
Oxaliplatin
4
Dexamethasone
4
sargramostim
3
Vinblastine
3
Taxes
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Methylprednisolone
3
Methods
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Testicular Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT07463508
2026-03-11
TG-BIL
University Hospital, Clermont-Ferrand
Phase NA
Recruiting
20 enrolled